Researchers have confirmed that interleukin-6 (IL-6) increased the activation of AR in pancreatic cancer cells by upregulating the phosphorylation of signal transducer and activator of transcription 3 (STAT3) and mitogen-activated protein kinase (MAPK). The gene discussed is AR; the disease is familial pancreatic carcinoma.